Aspire Biopharma Holdings, Inc. (ASBP): SCHEDULE 13G filed Feb 12, 2026

Form type

SCHEDULE 13G

Filing date

Feb 12, 2026

Accession number

0001213900-26-015382

Filer

Aspire Biopharma Holdings, Inc. (CIK 1847345)